Drawing for BIOALIGN

USPTO serial 99425019

BIOALIGN

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOALIGN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas L Lineberry

Douglas L Lineberry Offit Kurman220 North Main StreetSuite 500Greenville, SC 29601

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for health purposes,, namely, software for finding remedies for physical and mental conditions; Downloadable computer software platforms for finding remedies for physical and mental conditions; Downloadable computer application software for mobile phones, namely, software for finding remedies for physical and mental conditions; Computer software platforms, downloadable, for finding remedies for physical and mental conditions; Downloadable computer software and firmware for finding remedies for physical and mental conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 13, 2025MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Nov 13, 2025ABN1ABANDONMENT - EXPRESS MAILED—
Nov 12, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 8, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance